Skip to content

The influence of acute hypervolemic hemodilution on the Propofol EC 50 for trachea intubation

The influence of acute hypervolemic hemodilution on the Propofol EC 50 for trachea intubation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007826
Enrollment
Unknown
Registered
2016-01-25
Start date
2016-01-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc disease,Gynecological tumors,Abdominal tumor,Chronic sinusitis

Interventions

Sponsors

Department of Anesthesiology,The first people's hosipital of Shunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients with ages of 20–65 years, BMI: 18.5-30 kg/m2, ASA I–II, undergoing elective Orthopaedic surgery, ENT surgery; 2. Gynecologic surgery were or General surgery were enrolled on the study.

Exclusion criteria

Exclusion criteria: 1. refused to participate; 2. Potentially difficult airway; 3. Without regular treatment of poorly controlled hypertension; 4. hepatic or renal dysfunction; 5. Cardiovascular disease or dysfunction of blood coagulation; 6. hematocrit less than 35%, Hb less than 110 g/L; 7. allergy.

Design outcomes

Primary

MeasureTime frame
Positive reaction of trachea intubation;

Secondary

MeasureTime frame
Hb and HCt;MAP and HR;The usage of vascular drugs;

Countries

China

Contacts

Public ContactChen Hanwen
53918749@qq.com+86 13724671233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026